Age (y) |
80.5 (± 6.81) |
80.2 (± 7.92) |
0.54 |
Male |
202 (70 %) |
709 (58 %) |
0.03a
|
Female |
88 (30 %) |
507 (42 %) |
0.04
a
|
NYHA III-IV |
226 (78 %) |
1216 (100 %) |
0.058 |
CCS 3-4 |
41 (14 %) |
163 (13 %) |
0.62 |
Logistic Euro-SCORE |
22 (±1.6) |
20 (±2.3) |
0.06 |
Frailty score (CSHA) 6 -7 |
19 (7 %) |
85 (7%) |
0.98 |
Katz index (1-2) |
2 (0.7 %) |
12 (1 %) |
0.89 |
Poor mobility |
29 (10 %) |
127 (10 %) |
0.98 |
Critical preoperative status |
4 (1 %) |
13 (1 %) |
0.99 |
Height (m) |
1.66 (± 0.10) |
1.63 (± 0.10) |
0.79 |
Weight (kg) |
74.35 (±17.45) |
74.31 (±15.42) |
0.75 |
Creatinine (mmol/l) |
115 (± 60.80) |
120 (±23.01) |
0.42 |
Pre op dialysis |
1 (0.34 %) |
4 (0.32 %) |
0.41 |
Diabetes |
79 (27 %) |
328 (27 %) |
0.92 |
Insulin
|
13 (16 %)
|
195 (16 %)
|
0.92
|
Oral drugs
|
45 (57 %)
|
681 (56 %)
|
0.89
|
Diet treatment
|
21 (27 %)
|
340 (28 %)
|
0.90
|
Non-diabetic
|
211 (73 %)
|
888 (73 %)
|
0.94
|
Current smoker |
24 (8 %) |
97 (8 %) |
0.97 |
Ex-smoker |
177 (61 %) |
705 (58 %) |
0.89 |
Never smoker |
89 (31 %) |
413 (34 %) |
0.88 |
COPD/Pulmonary disease |
89 (31 %) |
378 (31 %) |
0.98 |
Severe liver disease |
2 (0.7 %) |
12 (1 %) |
0.87 |
Atrial fibrillation |
74 (26 %) |
255 (21 %) |
0.78 |
Neurological disease |
65 (22 %) |
231 (19 %) |
0.85 |
Extracardiac arteriopathy |
152 (52 %) |
632 (52 %) |
0.98 |
Ascending aorta calcification |
65 (22 %) |
280 (23 %) |
0.84 |
Previous cardiac surgery |
86 (30%) |
556 (46%) |
0.15 |
Previous MI |
75 (26 %) |
328 (27 %) |
0.81 |
Previous PCI |
75 (26 %) |
194 (16 %) |
0.76 |
Coronary artery disease |
141 (49 %) |
559 (46 %) |
0.68 |
LMS disease > 50 % |
19 (6 %) |
61 (5 %) |
0.55 |
LVEF > 50 % |
155 (54 %) |
705 (58 %) |
0.61 |
LVEF 30-49 % |
107 (37 %) |
389 (32 %) |
0.54 |
LVEF < 30% |
26 (9 %) |
122 (10 %) |
0.46 |
Aortic peak gradient (mmHg) |
78.03 (± 28.99) |
76.03 (± 29.19) |
0.43 |
Aortic mean gradient (mmHg) |
48.06 (± 15.37) |
47.06 (± 19.37) |
0.64 |
Aortic valve area (cm2) |
1.07 (± 4.72) |
1.02 (±
4.74) |
0.45 |
Aortic annulus (mm) |
23.76 (± 2.82) |
23.71 (± 2.12) |
0.34 |
MVR (moderate-severe) |
20 (7 %) |
97 (8 %) |
0.09 |